Advertisement

Picture [iito] Made Without Love 650x80px
Organisation › Details

Dementia Discovery Fund (DDF) (UK govt et al.)

The DDF is a venture capital fund which invests in projects and companies to discover and develop novel, effective disease-modifying therapeutics for dementia. Seven leading pharmaceutical companies (Biogen, Eli Lilly and Company, GSK, Johnson & Johnson, Otsuka (Astex), Pfizer and Takeda), Bill Gates, Woodford Investment Management via Woodford Patient Capital Trust (WPCT), the NFL Players Association, the UK’s Department of Health and charity Alzheimer’s Research UK have invested in the DDF to date. Heads of Neuroscience and R&D represent these strategic investors on the DDF Scientific Advisory Board and work closely with SV’s dedicated team of neuroscientists and experts to identify and evaluate novel approaches for the treatment of dementia. SV won the bid to become Manager in a competitive selection process held in 2015. *

 

Period Start 2015-03-17 established (approx)
  Group SV Health Investors (Group)
Products Industry venture capital
  Industry 2 drug discovery
Persons Person Grant, Angus (BeiGene 202007– Chief Business Executive before Dementia Discovery Fund + Celgene)
  Person 2 Jung, Christian Billy (Dementia Discovery Fund 202106 Partner formerly HTGF 201305 Investment Manager)
     
Region Region United Kingdom (town unspecified)
  Country United Kingdom (GB)
  City n. a. 
    Address record changed: 2021-06-05
     
Basic data Employees n. a.
  Currency GBP
  Annual sales 2,500,000,000 (fund size (2021) 2021-06-02)
     
    * Document for �About Section�: Immuneering Corporation. (6/18/18). "Press Release: The Dementia Discovery Fund and Immuneering Announce a Research Collaboration to Identify Novel Drug Targets and Drug Candidates for Alzheimer's Disease". Cambridge, MA & London.
     
   
Record changed: 2021-06-05

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for SV Health Investors (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture [iito] Back into Ad 650x80px




» top